Hannah Yang

45.5k total citations · 1 hit paper
84 papers, 2.8k citations indexed

About

Hannah Yang is a scholar working on Oncology, Genetics and Immunology. According to data from OpenAlex, Hannah Yang has authored 84 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Oncology, 22 papers in Genetics and 20 papers in Immunology. Recurrent topics in Hannah Yang's work include Endometrial and Cervical Cancer Treatments (16 papers), Ovarian cancer diagnosis and treatment (14 papers) and Estrogen and related hormone effects (13 papers). Hannah Yang is often cited by papers focused on Endometrial and Cervical Cancer Treatments (16 papers), Ovarian cancer diagnosis and treatment (14 papers) and Estrogen and related hormone effects (13 papers). Hannah Yang collaborates with scholars based in United States, South Korea and United Kingdom. Hannah Yang's co-authors include Chan Kim, Hong Jae Chon, Won Suk Lee, Louise A. Brinton, Nicolas Wentzensen, Mark E. Sherman, Britton Trabert, Ashley S. Felix, So Jung Kong and Yikyung Park and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Investigation and Nature Communications.

In The Last Decade

Hannah Yang

83 papers receiving 2.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Combination of anti-angiogenic therapy and immune checkpoint blockade normalizes vascular-immune crosstalk to potentiate cancer immunity

2020 434 citations Won Suk Lee, Hannah Yang et al. Experimental & Molecular Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Hannah Yang United States	30	1.1k	872	729	512	497	84	2.8k
Rebecca C. Arend United States	35	1.1k 1.0×	1.7k 1.9×	510 0.7×	513 1.0×	668 1.3×	162	3.6k
Dan Cacsire Castillo‐Tong Austria	35	1.1k 1.0×	1.4k 1.6×	489 0.7×	321 0.6×	900 1.8×	101	3.2k
Thomas A. Caputo United States	26	484 0.4×	581 0.7×	458 0.6×	575 1.1×	637 1.3×	97	2.5k
B.J. Rimel United States	23	1.4k 1.3×	760 0.9×	286 0.4×	369 0.7×	1.1k 2.2×	113	2.6k
Line Bjørge Norway	32	583 0.5×	633 0.7×	764 1.0×	1.0k 2.0×	683 1.4×	138	2.9k
Richard J. Edmondson United Kingdom	36	1.4k 1.2×	1.3k 1.5×	259 0.4×	978 1.9×	1.2k 2.4×	128	3.6k
Kian Behbakht United States	34	1.2k 1.1×	1.7k 1.9×	319 0.4×	584 1.1×	1.1k 2.2×	127	3.9k
Thomas Bauknecht Germany	27	777 0.7×	846 1.0×	585 0.8×	213 0.4×	581 1.2×	82	2.2k
Bei Lin China	28	621 0.6×	1.7k 1.9×	593 0.8×	179 0.3×	485 1.0×	156	2.8k
Hiroyuki Kuramoto Japan	29	661 0.6×	1.2k 1.4×	379 0.5×	1.1k 2.1×	934 1.9×	146	3.1k

Countries citing papers authored by Hannah Yang

Since Specialization

Citations

This map shows the geographic impact of Hannah Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hannah Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hannah Yang more than expected).

Fields of papers citing papers by Hannah Yang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hannah Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hannah Yang. The network helps show where Hannah Yang may publish in the future.

Co-authorship network of co-authors of Hannah Yang

This figure shows the co-authorship network connecting the top 25 collaborators of Hannah Yang. A scholar is included among the top collaborators of Hannah Yang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hannah Yang. Hannah Yang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Yang, Hannah, Chan Kim, & Weiping Zou. (2024). Metabolism and macrophages in the tumor microenvironment. Current Opinion in Immunology. 91. 102491–102491. 12 indexed citations

Conway, Michael J., et al.. (2024). Chronic shedding of a SARS-CoV-2 Alpha variant in wastewater. BMC Genomics. 25(1). 59–59. 4 indexed citations

Yang, Hannah, Wooram Park, Seung Joon Lee, et al.. (2023). Systemic Delivery of a STING Agonist‐Loaded Positively Charged Liposome Selectively Targets Tumor Immune Microenvironment and Suppresses Tumor Angiogenesis. Small. 19(43). e2300544–e2300544. 15 indexed citations

Lee, Won Suk, Chang Woo Kim, Seung Joon Lee, et al.. (2020). Oncolytic vaccinia virus reinvigorates peritoneal immunity and cooperates with immune checkpoint inhibitor to suppress peritoneal carcinomatosis in colon cancer. Journal for ImmunoTherapy of Cancer. 8(2). e000857–e000857. 47 indexed citations

Yang, Hannah, Hong Jae Chon, Da Som Yang, et al.. (2020). Combination of Irreversible Electroporation and STING Agonist for Effective Cancer Immunotherapy. Cancers. 12(11). 3123–3123. 40 indexed citations

Lee, Won Suk, Hannah Yang, Hong Jae Chon, & Chan Kim. (2020). Combination of anti-angiogenic therapy and immune checkpoint blockade normalizes vascular-immune crosstalk to potentiate cancer immunity. Experimental & Molecular Medicine. 52(9). 1475–1485. 434 indexed citations breakdown →

Chon, Hong Jae, Hyojoong Kim, Jung Hyun Noh, et al.. (2019). STING signaling is a potential immunotherapeutic target in colorectal cancer. Journal of Cancer. 10(20). 4932–4938. 64 indexed citations

Park, Intae, Hannah Yang, Jin‐Sung Park, Gou Young Koh, & Eun Kyung Choi. (2018). VEGF-Grab Enhances the Efficacy of Radiation Therapy by Blocking VEGF-A and Treatment-Induced PlGF. International Journal of Radiation Oncology*Biology*Physics. 102(3). 609–618. 6 indexed citations

Murphy, Jeanne, Ruth M. Pfeiffer, Brittny C. Davis Lynn, et al.. (2018). Pro-inflammatory cytokines and growth factors in human milk: an exploratory analysis of racial differences to inform breast cancer etiology. Breast Cancer Research and Treatment. 172(1). 209–219. 15 indexed citations

10.

Kim, Chan, Hannah Yang, Intae Park, et al.. (2016). Rho GTPase RhoJ is Associated with Gastric Cancer Progression and Metastasis. Journal of Cancer. 7(11). 1550–1556. 17 indexed citations

11.

Trabert, Britton, Nicolas Wentzensen, Ashley S. Felix, et al.. (2015). Metabolic Syndrome and Risk of Endometrial Cancer in the United States: A Study in the SEER–Medicare Linked Database. Cancer Epidemiology Biomarkers & Prevention. 24(1). 261–267. 110 indexed citations

12.

Yang, Hannah, Alan K. Meeker, Richard S. Guido, et al.. (2015). PTEN expression in benign human endometrial tissue and cancer in relation to endometrial cancer risk factors. Cancer Causes & Control. 26(12). 1729–1736. 29 indexed citations

13.

Lee, Jung‐Eun, Chan Kim, Hannah Yang, et al.. (2014). Novel Glycosylated VEGF Decoy Receptor Fusion Protein, VEGF-Grab, Efficiently Suppresses Tumor Angiogenesis and Progression. Molecular Cancer Therapeutics. 14(2). 470–479. 23 indexed citations

14.

Wentzensen, Nicolas, Jamie N. Bakkum‐Gamez, Jonathan Keith Killian, et al.. (2014). Discovery and validation of methylation markers for endometrial cancer. International Journal of Cancer. 135(8). 1860–1868. 55 indexed citations

15.

Felix, Ashley S., Hannah Yang, Gretchen L. Gierach, Yikyung Park, & Louise A. Brinton. (2014). Cigarette smoking and endometrial carcinoma risk: the role of effect modification and tumor heterogeneity. Cancer Causes & Control. 25(4). 479–489. 29 indexed citations

16.

Murphy, Megan, Britton Trabert, Hannah Yang, et al.. (2012). Non-steroidal anti-inflammatory drug use and ovarian cancer risk: findings from the NIH-AARP Diet and Health Study and systematic review. Cancer Causes & Control. 23(11). 1839–1852. 27 indexed citations

17.

Trabert, Britton, Nicolas Wentzensen, Hannah Yang, et al.. (2012). Is estrogen plus progestin menopausal hormone therapy safe with respect to endometrial cancer risk?. International Journal of Cancer. 132(2). 417–426. 58 indexed citations

18.

Yang, Hannah, Gretchen L. Gierach, Kim N. Danforth, et al.. (2010). Alcohol and endometrial cancer risk in the NIH‐AARP diet and health study. International Journal of Cancer. 128(12). 2953–2961. 10 indexed citations

19.

Zhan, Chunliu, Ed Kelley, Hannah Yang, et al.. (2005). Assessing Patient Safety in the United States. Medical Care. 43(Supplement). I–42. 24 indexed citations

20.

Lee, Soon Young, Miyong T. Kim, Sun Ha Jee, & Hannah Yang. (2005). Does long-term lactation protect premenopausal women against hypertension risk? a Korean women's cohort study. Preventive Medicine. 41(2). 433–438. 57 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact